Combinations of microfluidic diagnostic testing modules for simultaneous evaluations of serological and molecular biological targets are provided, and include panel testing for both antibodies (or antigens) and nucleic acid targets in one single-use device. These improvements are directed to evaluating the overall progress and activity of a pathogenic process in real time, at the point of care, not merely the presence or absence of a particular diagnostic marker, which can often be incomplete or misleading.

 
Web www.patentalert.com

< ONE-COMPONENT STRUCTURAL ADHESIVE HAVING HIGH INITIAL ADHESION

> COATED ABRASIVE ARTICLES AND METHODS OF MAKING AND USING THE SAME

> Ultrastable Particle-Stabilized Foams and Emulsions

~ 00571